A A A

Close
<Return
Ask me anything
about CR EXPO
与50,000专业买家共赴中国最大的福祉康复盛会

Press Release

Booth Application Visitor Pre-registration

[Exhibitor Recommendation] Beijing Hengzhuo Technology Holding Co., Ltd.

Press Release 2017.04.19

Integrating product research and development, manufacturing and marketing, Beijing Hengzhuo Technology Holding Co., Ltd. provides integrated hearing solutions for severe and profound sensorineural hearing loss patients. Working with domestically and internationally leading research and medical institutions, colleges and universities, the Company has been engaged in the research of cochlea implant programs for 20 years supported by high-level talents in audiology, medical science and rehabilitation science.

Clinically tested, the AIC cochlea implant certified by CFDA in 2015 is applicable to patients of all age groups over 6 months old.

The AIC cochlea implant is a professional and safe solution that offers high-grade, high-precision and high-end quality experience for severe and profound sensorineural hearing loss patients.


Features of AIC Cochlea Implant

1. The unconventionally-designed implant is extremely small, thin and light; it can be fastened without cutting the bone groove during the surgery to keep the natural defense of skull intact, and lower the possibility of displacement, come-off and violent injury after the implantation; the small-surface wound can be quickly healed and patients will have the slightest discomfort after the implantation.  


 

2. With perfect vertical compatibility and proprietary external chip design, the implant can effectively prevent device failure resulting from the aging of electronic components; the implant can be used for life, upgraded without a second surgery, lasting and more reliable.  


 

3. Designed with finer electrode wires and smaller stimulating electrodes, the implant requires a small opening on the cochlea and effectively reduces the possibility of additional damage during the surgery. 


4. A shallow insertion of short electrodes protects the residual hearing. The functionally adequate product features a relatively shallow insertion to prevent damage to the deep structure of cochlea and minimize the damage to the hair cells in the cochlea. The residual hearing is protected and overall structure of cochlea kept intact to maximally leave the option of future scientific results open.  


 

5. The sound processor of the AIC cochlea implant is the only sound processing system that offers continuous signals of time domain and frequency domain in the industry. It can deliver high fidelity sounds closest to the original voices. The minimal integrated design dispenses with wearing on the external ear.。


 

 

In 2016, AIC cochlea implant relied on its high-grade, high-precision and advanced technology and won the bid for the Cochlea Implant Procurement Project of Shengjing Hospital Affiliated to China Medical University, a far-reaching event in the cochlea implant market. AIC is the only Chinese brand selected by Shengjing Hospital among the domestically and internationally famous brands.